Giustozzi, Michela http://orcid.org/0000-0002-8033-4945
Mazzetti, Matteo
Paciaroni, Maurizio
Agnelli, Giancarlo
Becattini, Cecilia
Vedovati, Maria Cristina
Funding for this research was provided by:
Università degli Studi di Perugia
Article History
Accepted: 24 October 2020
First Online: 7 December 2020
Declarations
:
: Open access funding provided by Università degli Studi di Perugia within the CRUI-CARE Agreement.
: Michela Giustozzi, Matteo Mazzetti and Maria Cristina Vedovati have no conflict of interest to declare. Maurizio Paciaroni received honoraria as a member of the speaker bureau of Aspen, Sanofi-Aventis, Boehringer Ingelheim, Bayer, Bristol Meyer Squibb, Daiiki Sankyo and Pfizer. Giancarlo Agnelli received honoraria as a member of the speaker bureau of Bristol-Meyers-Squibb, Pfizer and Bayer. Cecilia Becattini received honoraria as a member of the speaker bureau of Bristol-Meyers-Squibb, Pfizer, Bayer and Boehringer Ingelheim.
: All procedures in this study were in accordance with the 1964 Helsinki declaration and its amendments. The study was approved by the local institutional review board.
: Written informed consent was obtained from patients, parents or caregivers.
: Data that support the findings of this study are available from the corresponding author upon reasonable request.
: Not applicable.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Michela Giustozzi contributed to the interpretation of data, drafting and critical revision of the manuscript and is the guarantor of the paper, taking responsibility for the integrity of the work as a whole, from inception to published article; Matteo Mazzetti, Maurizio Paciaroni, Giancarlo Agnelli, Cecilia Becattini and Maria Cristina Vedovati contributed to the conception and design of the study, to the statistical analyses, to the interpretation of data, drafting and critical revision of the manuscript.